From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.03
First Reported 2001
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 2
Total Number 2
Disease Relevance 2.58
Pain Relevance 0.27

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

EDSS2 (Homo sapiens)
Pain Link Frequency Relevance Heat
Neuritis 1 93.88 High High
imagery 1 89.88 High High
headache 1 86.88 High High
Inflammation 10 84.56 Quite High
Spinal cord 10 27.44 Quite Low
Central nervous system 11 5.00 Very Low Very Low Very Low
Multiple sclerosis 2 5.00 Very Low Very Low Very Low
depression 1 5.00 Very Low Very Low Very Low
dexamethasone 1 5.00 Very Low Very Low Very Low
Pain 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Syndrome 6 99.86 Very High Very High Very High
Disease 15 99.56 Very High Very High Very High
Chronic Progressive Multiple Sclerosis 1 99.14 Very High Very High Very High
Intracranial Sinus Thrombosis 7 96.48 Very High Very High Very High
Optic Neuritis 1 93.88 High High
Multiple Sclerosis 102 87.08 High High
Headache 1 86.88 High High
INFLAMMATION 10 84.56 Quite High
Toxicity 3 80.92 Quite High
Hypersensitivity 1 56.56 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Ten years from onset of BD 45.1% (all NBS) reached a disability level of EDSS 6 or higher, and 95.7 +/- 2.1% of the patients were still alive.
Positive_regulation (ed a di) of EDSS 6 associated with syndrome and disease
1) Confidence 0.03 Published 2001 Journal J. Neurol. Section Abstract Doc Link 11284141 Disease Relevance 1.94 Pain Relevance 0.27
The available clinical data show that the key inclusion criteria for the therapeutic window in humans in an open clinical trial would be: a) disability, as evaluated by the expanded disability status scale (EDSS) in patients with Secondary Progressive Multiple Sclerosis (SPMS) (EDSS 3-6.5); b) a minimum 1-point increase in EDSS during the 24 months prior to the beginning of the clinical trial.
Positive_regulation (increase) of EDSS associated with chronic progressive multiple sclerosis
2) Confidence 0.01 Published 2008 Journal International Journal of Biological Sciences Section Body Doc Link PMC2407579 Disease Relevance 0.64 Pain Relevance 0

General Comments

This test has worked.

Personal tools